Price Alert

BioMarin Pharmaceutical I... (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

57.88

-0.12 (-0.21%)

At close: Aug 15, 2025, 12:48 PM

BioMarin Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	825.41M	745.14M	738.22M	745.74M	708.66M	648.83M	646.21M	585.97M	594.6M	592.95M	537.54M	505.34M	533.8M	519.36M	449.81M	408.74M	501.69M	486.03M
Cost of Revenue	150.09M	151.56M	136.14M	188.46M	144.76M	139.48M	135.48M	140.43M	143.68M	142.25M	127.29M	116.29M	123.13M	116.97M	119.75M	103.54M	127.06M	120.17M
Gross Profit	675.32M	593.59M	602.08M	557.28M	563.9M	509.36M	510.73M	445.54M	450.92M	450.7M	410.25M	389.06M	410.67M	402.39M	330.06M	305.2M	374.63M	365.86M
Operating Income	276.89M	223.89M	161.41M	113.89M	103.46M	81.86M	14.22M	22.83M	56.77M	60.47M	-13.93M	2.77M	39.15M	29.99M	-65.88M	-53.22M	11.67M	25.09M
Interest Income	18.83M	19.01M	17.68M	18.05M	19.79M	19.36M	18.04M	15.74M	12.61M	11.94M	8.71M	5M	2.5M	1.82M	1.75M	1.83M	4.47M	2.44M
Pretax Income	297.87M	238.09M	169.64M	134.44M	132.14M	105.55M	19.33M	41.67M	70.81M	56.76M	-17.56M	-1.9M	34.85M	134.19M	-66.57M	-46.16M	14.16M	23.23M
Net Income	240.53M	185.69M	124.94M	106.08M	107.17M	88.66M	20.38M	40.38M	56.04M	50.85M	-249K	-6.65M	27.66M	120.8M	-57.9M	-36.49M	12.94M	17.37M
Selling & General & Admin	232.28M	206.12M	280.8M	253.48M	263.03M	222.51M	275.02M	172.6M	216.78M	218.38M	245.74M	216.82M	196.84M	194.62M	217.56M	183.33M	184.16M	174.32M
Research & Development	161.31M	158.73M	173.51M	184.9M	183.79M	204.99M	206.25M	191.31M	177.36M	171.85M	172.75M	157.83M	158.19M	160.84M	161.09M	157.87M	161.11M	148.72M
Other Expenses	4.85M	4.85M	9.66M	5.01M	-4.53M	n/a	-15.24M	4.05M	3.08M	n/a	16.26M	16.83M	16.5M	17.61M	1.41M	8.93M	2M	858K
Operating Expenses	398.43M	369.69M	449.77M	443.39M	460.44M	427.49M	496.51M	422.71M	394.14M	390.23M	434.75M	391.47M	371.52M	373.07M	395.94M	358.42M	362.96M	340.78M
Interest Expense	-2.68M	-2.86M	2.58M	2.97M	3.57M	3.55M	6.1M	3.78M	3.75M	3.7M	3.63M	4.68M	3.86M	3.81M	3.85M	3.87M	3.82M	3.8M
Selling & Marketing Expenses	n/a	n/a	34.5M	108.9M	122.8M	n/a	133.2M	121.9M	115.6M	117.7M	124.6M	111.3M	109.4M	104.9M	113.1M	97M	100.9M	94.2M
Cost & Expenses	548.52M	521.25M	585.91M	631.85M	605.2M	566.97M	631.99M	563.13M	537.83M	532.48M	562.04M	507.76M	494.65M	490.03M	515.69M	461.96M	490.02M	460.94M
Income Tax Expense	57.34M	52.4M	44.7M	28.36M	24.96M	16.89M	-1.05M	1.29M	14.77M	5.91M	-17.31M	4.75M	7.19M	13.39M	-8.68M	-9.67M	1.22M	5.86M
Shares Outstanding (Basic)	191.44M	190.97M	190.69M	190.43M	190.11M	188.87M	188.48M	188.22M	187.95M	186.67M	186.03M	185.6M	185.25M	190.53M	181.6M	182.47M	182.84M	181.77M
Shares Outstanding (Diluted)	196.64M	196.47M	196.58M	197.15M	200.5M	199.26M	191.84M	191.17M	195M	194.36M	186.03M	185.6M	187.45M	194.89M	183.55M	183.21M	185.43M	184.37M
EPS (Basic)	1.26	0.97	0.66	0.57	0.56	0.47	0.11	0.21	0.30	0.27	-0.00	-0.04	0.15	0.63	-0.32	-0.2	0.07	0.10
EPS (Diluted)	1.24	0.95	0.64	0.55	0.55	0.44	0.11	0.21	0.29	0.26	-0.00	-0.04	0.15	0.62	-0.32	-0.2	0.07	0.09
EBITDA	306.52M	223.89M	195.82M	156.41M	162.17M	136.44M	52.29M	71.13M	99.98M	86.88M	10.43M	27.58M	63.98M	165.34M	-37.34M	-15.45M	45.19M	55.03M
EBIT	n/a	235.23M	172.22M	137.41M	135.71M	109.09M	24.83M	45.45M	74.56M	60.46M	-14.53M	2.77M	38.71M	137.99M	-63.32M	-42.29M	17.97M	27.03M
Depreciation & Amortization	11.33M	-11.33M	23.61M	19.01M	26.46M	27.35M	26.86M	25.68M	25.42M	26.42M	24.36M	24.8M	25.27M	27.34M	25.98M	26.84M	27.22M	28M